Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Alethea Capital Management
AddedFeb 15, 2024
UpdatedJun 28, 2026
Alethea Capital Management

Alethea Capital Management

Operating

Alethea Capital Management: A California-based investment firm offering asset management, financial planning, and advisory services.

Location
San Diego, CA, US
Founded
2011
Firm
Compare
Portfolio
Employees
Website

Alethea Capital Management is a California-based investment firm specializing in early-stage venture opportunities, particularly in biotechnology and health technology sectors. The firm typically participates in Seed, Series A, Series B, and Series C funding rounds, with a focus on nurturing entrepreneurial founders who pursue unconventional paths to create impactful innovations.

Notable portfolio companies include Avidity Biosciences, Presidium Health, rightdevice, and SEngine Precision Medicine. Alethea Capital Management is guided by a contrarian investment philosophy inspired by John Maynard Keynes, emphasizing the importance of unconventional success. The firm offers unique value-add services such as asset management, financial planning, and advisory services to support the growth and success of its portfolio companies.

Alethea Capital Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments6
Current Portfolio Count5
Total Portfolio Exits0

Top Investment Stages

Series A3 (50.0%)
Seed1 (16.7%)
Series B1 (16.7%)
Series C1 (16.7%)

Stage Mix

Series A 50%Seed 17%Series B 17%Series C 17%

Concentration shown as share of disclosed investments by stage.

Recent Investments

SEngine Precision Medicine logo

SEngine Precision Medicine

rightdevice logo

rightdevice

Lipidio Pharmaceuticals logo

Lipidio Pharmaceuticals

Presidium Health logo

Presidium Health

Avidity Biosciences logo

Avidity Biosciences

Alethea Capital Management - Similar Investment Firms

Althea Ventures logo

Althea Ventures

altheagroup.com

Atheneos Capital logo

Atheneos Capital

Althea logo

Althea

althea.one

Aleka Capital logo

Aleka Capital

alekacapital.com

Alkeon Capital Management logo

Alkeon Capital Management

alkeoncapital.com

Aliya Capital Partners logo

Aliya Capital Partners

Alaya Capital logo

Alaya Capital

alaya-capital.com

Alta Partners logo

Alta Partners

altapartners.com

Aleph Capital Partners logo

Aleph Capital Partners

aleph.com

Avalon BioVentures logo

Avalon BioVentures

Alecla7 logo

Alecla7

alecla7.com

Aquilo Capital Management logo

Aquilo Capital Management

aquilocap.com

Aphelion Capital logo

Aphelion Capital

Align Capital logo

Align Capital

aligncapital.com

Atalaya Capital Management logo

Atalaya Capital Management

atalayacap.com

Alethea Capital Management - Classification

Also Known As
  • Alethea Capital Management, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions